🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Viral Hepatitis

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site📍 Hong Kong Chinese University of Hong Kong · Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study） NCT06323681NA1 site📍 Shanghai Qing XIe · Tests: Peginterferon α-2b based treatment group, NAs monotherapy group Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site📍 Hong Kong Humanity & Health Medical Group Limited · Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site📍 Beijing Beijing Friendship Hospital · Tests: Nucleos(t)ide Analogs (NA) Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF NCT03920618NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). NCT07487623NA2 sites📍 Guadalajara📍 Guadalajara University of Guadalajara · Tests: resveratrol, quercetin, taurine, whey protein, and inulin, whey protein Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data NCT07419347n/a2 sites📍 Vancouver📍 Toronto AbbVie TAF (Tenofovir Alafenamide) for Preventing Progression of Liver Disease in Non-cirrhotic Chronic HBV Infection With Normal ALT and Low Viral Load. NCT05195450NA1 site📍 New Delhi Institute of Liver and Biliary Sciences, India · Tests: Tenofovir alafenamide fumarate Evaluation of Patients With Liver Disease NCT00001971n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… The Australian HCV Point-of-Care Testing Program NCT05042544n/a69 sites📍 Canberra📍 Bathurst📍 Broken Hill Kirby Institute · Tests: Point-of-Care Testing Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site📍 Shanghai Huashan Hospital · Tests: peginterferon alpha based regimen, nucleos(t)ide Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance NCT07257562n/a1 site📍 Fuzhou First Affiliated Hospital of Fujian Medical University · Tests: PegIFNα2b+Nucleoside analog, PegIFNα2b+Nucleoside analog+Bacteroides fragilis+Branched-Chain Amino Acids Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide NCT07429864n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B NCT03933384Phase 41 site📍 Taichung Taichung Veterans General Hospital · Tests: Tenofovir alafenamide, Entecavir TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants NCT06544863n/a3 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Data collection; biological samples Early Detection of HCV in Injection Drug Users NCT06431945n/a18 sites📍 Brno📍 Brno📍 České Budějovice Institute of Health Information and Statistics of the Czech… · Tests: Hepatitis C antibody (anti-HCV) test, Hepatitis C RNA test and genotype test Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection NCT07610772Phase 12 sites📍 Aarhus📍 Berlin Aarhus University Hospital · Tests: HepB mAb19 Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria NCT06834178n/a1 site📍 Graz Vanessa Stadlbauer-Koellner, MD A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B NCT07389044Phase 15 sites📍 Hong Kong📍 Hong Kong📍 Chisinau IntegerBio · Tests: IB-001, Placebo, Peginterferon Alfa-2A Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site📍 New York NYU Langone Health Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B NCT06671093Phase 13 sites📍 Hong Kong📍 Chisinau📍 Auckland Tune Therapeutics, Inc. · Tests: Tune-401 "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico. NCT07317011n/a1 site📍 Bergamo FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine NCT03609398Phase 21 site📍 Fort Deterick U.S. Army Medical Research and Development Command · Tests: RVF Vaccine Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA. NCT04231565NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: Tenofovir alafenamide Fumarate Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis NCT05905172Phase 323 sites📍 Beijing📍 Shanghai📍 Beijing Beijing Continent Pharmaceutical Co, Ltd. · Tests: Hydronidone capsules, The placebo capsules ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection NCT07573943Phase 41 site📍 Chongqing The Second Affiliated Hospital of Chongqing Medical Univers… · Tests: Anti-PD-L1 antibody (ASC22), Nucleotide analogs, Peg-IFNα A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) NCT07200908Phase 357 sites📍 Graz📍 Sankt Pölten📍 Brno Mirum Pharmaceuticals, Inc. · Tests: Brelovitug 300 mg, Bulevirtide 2 mg and Brelovitug - 300 mg Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum NCT04162938NA1 site📍 Baltimore Johns Hopkins University · Tests: Patient-Centered Electronic App
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy